N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide
C43H31BrF2N12O4S — CID 157312761
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide
N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide (PubChem CID 157312761) has the molecular formula C43H31BrF2N12O4S and a molecular weight of 929.77 g/mol. Its IUPAC name is N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide.
Molecular Properties
| Compound Name | N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide |
|---|---|
| PubChem CID | 157312761 |
| Molecular Formula | C43H31BrF2N12O4S |
| Molecular Weight | 929.77 g/mol |
| Exact Mass | 928.15 |
| IUPAC Name | N-[(1S)-1-(2-bromo-4-pyridinyl)-2-cyanoethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-2-cyano-1-(2-methylsulfonyl-4-pyridinyl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide |
| SMILES | CS(=O)(=O)c1cc([C@H](CC#N)NC(=O)c2cncc3c2cnn3-c2ccc(F)cc2)ccn1.N#CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(Br)c1 |
| InChI | InChI=1S/C22H17FN6O3S.C21H14BrFN6O/c1-33(31,32)21-10-14(7-9-26-21)19(6-8-24)28-22(30)18-11-25-13-20-17(18)12-27-29(20)16-4-2-15(23)3-5-16;22-20-9-13(6-8-26-20)18(5-7-24)28-21(30)17-10-25-12-19-16(17)11-27-29(19)15-3-1-14(23)2-4-15/h2-5,7,9-13,19H,6H2,1H3,(H,28,30);1-4,6,8-12,18H,5H2,(H,28,30)/t19-;18-/m00/s1 |
| InChIKey | BDFRHINGQAULLH-ZXNOKPTOSA-N |
| XLogP | 6.84 |
| TPSA | 227.12 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 929.77 |
| LogP ≤ 5 | 6.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157312761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.